최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of clinical pathology, v.70 no.3, 2017년, pp.260 - 265
Yeo, Min-Kyung (Department of Pathology and Medical Science, Chungnam National University School of Medicine, , Daejeon, Korea) , Jung, Min-Kyu (Department of Pathology and Medical Science, Chungnam National University School of Medicine, , Daejeon, Korea) , Lee, Su-Yel (Biobank of Chungnam National University Hospital, , Daejeon, Korea) , Lee, Yong-Moon (Department of Pathology and Medical Science, Chungnam National University School of Medicine, , Daejeon, Korea) , Hur, Gang Min (Department of Pharmacology, Chungnam National University School of Medicine, , Daejeon, Korea) , Kim, Jin-Man (Department of Pathology and Medical Science, Chungnam National University School of Medicine, , Daejeon, Korea)
Introduction The BRAF V600E mutation is the most common genetic event in papillary thyroid carcinoma (PTC). The BRAF V600E mutational status has a significant diagnostic and prognostic role in PTC since it can be detected in 32%-87% of PTC by various molecular methods. Aim(s) A novel, fully automate...
Oncogene Dhillon 26 3279 2007 10.1038/sj.onc.1210421 MAP kinase signalling pathways in cancer
Ann Transl Med Karachaliou 3 265 2015 Melanoma: oncogenic drivers and the immune system
Proc Natl Acad Sci USA Franco 108 1615 2011 10.1073/pnas.1015557108 Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice
Endocr Relat Cancer Xing 12 245 2005 10.1677/erc.1.0978 BRAF mutation in thyroid cancer
Int J Cancer Gandolfi 137 1001 2015 10.1002/ijc.28976 Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma
Ann Surg Oncol Jeong 20 759 2013 10.1245/s10434-012-2494-0 BRAF (V600E) mutation analysis in papillary thyroid carcinomas by peptide nucleic acid clamp real-time PCR
Yonsei Med J Kim 45 818 2004 10.3349/ymj.2004.45.5.818 Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population
Thyroid Jung 22 791 2012 10.1089/thy.2011.0123 Mutational patterns and novel mutations of the BRAF gene in a large cohort of Korean patients with papillary thyroid carcinoma
JAMA Otolaryngol Head Neck Surg Davies 140 317 2014 10.1001/jamaoto.2014.1 Current thyroid cancer trends in the United States
Ann Surg Oncol Toniato 15 1518 2008 10.1245/s10434-008-9859-4 Papillary thyroid carcinoma: factors influencing recurrence and survival
Am J Med Mazzaferri 97 418 1994 10.1016/0002-9343(94)90321-2 Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer
Eur J Clin Invest Wang 46 146 2016 10.1111/eci.12577 Clinical impact of BRAF mutation on the diagnosis and prognosis of papillary thyroid carcinoma: a systematic review and meta-analysis
J Korean Med Sci Cho 29 1054 2014 10.3346/jkms.2014.29.8.1054 Clinicopathological features of rare BRAF mutations in Korean thyroid cancer patients
Oncogene Fukushima 22 6455 2003 10.1038/sj.onc.1206739 BRAF mutations in papillary carcinomas of the thyroid
Korean J Pathol Jeong 46 61 2012 10.4132/KoreanJPathol.2012.46.1.61 Detection of BRAF(V600E) mutations in papillary thyroid carcinomas by peptide nucleic acid clamp real-time PCR: a comparison with direct sequencing
Am J Clin Pathol Kang 139 759 2013 10.1309/AJCPN3ULH6YWBHPH Detection of BRAF V600E mutation with thyroid tissue using pyrosequencing: comparison with PNA-clamping and real-time PCR
Am J Clin Pathol Lee 133 802 2010 10.1309/AJCPO3F2ENKMDTUS Detection of BRAF mutations in thyroid nodules by allele-specific PCR using a dual priming oligonucleotide system
Health Technol Assess Snowsill 18 1 2014 10.3310/hta18580 A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome
Oncotarget Janku 6 26886 2015 10.18632/oncotarget.4723 BRAF mutation testing with a rapid, fully integrated molecular diagnostics system
Exp Mol Pathol Melchior 99 485 2015 10.1016/j.yexmp.2015.09.004 Multi-center evaluation of the novel fully-automated PCR-based Idylla BRAF Mutation Test on formalin-fixed paraffin-embedded tissue of malignant melanoma
Onco Targets Ther Spagnolo 8 157 2015 10.2147/OTT.S39096 BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies
Thyroid Falchook 25 71 2015 10.1089/thy.2014.0123 BRAF inhibitor dabrafenib in patients with metastatic BRAF-mutant thyroid cancer
J Gastrointest Oncol Corcoran 6 650 2015 New therapeutic strategies for BRAF mutant colorectal cancers
※ AI-Helper는 부적절한 답변을 할 수 있습니다.